| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |